Back

Welcome and Introductions, Program Overview.

31 August 2020 (12:45 - 12:48)
Organised by:
Congress Presentation Part of: Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl Cardiovascular Risk Assessment Open Access ESC Congress 2020

About the speaker

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

4 More presentations in this session

Presentation thumbnail
Hypertriglyceridaemia as a Causal Factor and Target for Therapy.
Professor B. Nordestgaard (Copenhagen, DK)
Video
Presentation thumbnail
Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.
Professor P. Steg (Paris, FR)
Video
Presentation thumbnail
Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.
Professor B. Nordestgaard (Copenhagen, DK)
Video
Presentation thumbnail
Live Q&A and Adjourn.
Professor P. Steg (Paris, FR) Professor B. Nordestgaard (Copenhagen, DK)
Video

Access the full session

Session thumbnail
Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Introduction
27 August 2023
thumbnail
Congress Presentation
ACS Program. Improving secondary prevention in patients admitted due to a myocardial infarction. First year experience
25 April 2024
thumbnail
Congress Session
ACNAP Doctoral Student Award
24 June 2023
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources